MEDITE Cancer Diagnostics, Inc. (MDIT)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
MEDITE Cancer Diagnostics Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | -0.821M |
| June 30, 2018 | -1.015M |
| March 31, 2018 | -1.641M |
| December 31, 2017 | -0.73M |
| September 30, 2017 | -0.463M |
| June 30, 2017 | -0.747M |
| March 31, 2017 | -0.645M |
| December 31, 2016 | 0.049M |
| September 30, 2016 | -0.398M |
| June 30, 2016 | -0.183M |
| March 31, 2016 | -0.559M |
| December 31, 2015 | 0.004M |
| September 30, 2015 | -0.031M |
| June 30, 2015 | -0.486M |
| March 31, 2015 | 0.125M |
| December 31, 2014 | |
| September 30, 2014 | -0.181M |
| June 30, 2014 | -1.12M |
| March 31, 2014 | -0.062M |
| December 31, 2013 | -0.045M |
| September 30, 2013 | -0.239M |
| June 30, 2013 | -0.128M |
| March 31, 2013 | -0.086M |
| December 31, 2012 | -0.077M |
| September 30, 2012 | -0.172M |
| Date | Value |
|---|---|
| June 30, 2012 | -0.193M |
| March 31, 2012 | -0.243M |
| December 31, 2011 | -0.189M |
| September 30, 2011 | -0.134M |
| June 30, 2011 | -0.16M |
| March 31, 2011 | -0.236M |
| December 31, 2010 | -0.24M |
| September 30, 2010 | -0.258M |
| June 30, 2010 | -0.451M |
| March 31, 2010 | -0.172M |
| December 31, 2009 | |
| September 30, 2009 | -0.049M |
| June 30, 2009 | -0.257M |
| March 31, 2009 | -1.101M |
| December 31, 2008 | |
| September 30, 2008 | -1.571M |
| June 30, 2008 | -2.095M |
| March 31, 2008 | -2.597M |
| December 31, 2007 | -0.985M |
| September 30, 2007 | -1.682M |
| June 30, 2007 | -1.832M |
| March 31, 2007 | -1.192M |
| December 31, 2006 | -1.232M |
| September 30, 2006 | -1.397M |
| June 30, 2006 | -1.593M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Dynatronics Corp. | -0.0933M |
| Urologix, Inc. | -- |
| Viveve Medical, Inc. | -- |
| Hemagen Diagnostics, Inc. | -- |
| Acutus Medical, Inc. | -- |